Log in to save to my catalogue

Pioneer of prostate cancer: past, present and the future of FOXA1

Pioneer of prostate cancer: past, present and the future of FOXA1

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6beb4ac0a4b24b42b4b1c71955d397ed

Pioneer of prostate cancer: past, present and the future of FOXA1

About this item

Full title

Pioneer of prostate cancer: past, present and the future of FOXA1

Publisher

Beijing: Higher Education Press

Journal title

Protein & cell, 2021-01, Vol.12 (1), p.29-38

Language

English

Formats

Publication information

Publisher

Beijing: Higher Education Press

More information

Scope and Contents

Contents

Prostate cancer is the most commonly diagnosed noncutaneous cancers in North American men. While androgen deprivation has remained as the cornerstone of prostate cancer treatment, resistance ensues leading to lethal disease. Forkhead box A1 (FOXA1) encodes a pioneer factor that induces open chromatin conformation to allow the binding of other trans...

Alternative Titles

Full title

Pioneer of prostate cancer: past, present and the future of FOXA1

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6beb4ac0a4b24b42b4b1c71955d397ed

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6beb4ac0a4b24b42b4b1c71955d397ed

Other Identifiers

ISSN

1674-800X

E-ISSN

1674-8018

DOI

10.1007/s13238-020-00786-8

How to access this item